Screening Quality Assurance visit report: NHS Breast Screening Programme Isle of Wight – Public Health England

The findings in this report relate to the quality assurance visit of the Isle of Wight screening service held on 21 November 2017. The unit consistently exceeds the national achievable standard for uptake of 70%. The overall uptake for the 50-70 age

Screening Quality Assurance visit report: NHS Cervical Screening Programme Bolton NHS Foundation Trust – Pulic Health England

The findings in this report relate to the quality assurance (QA) visits of the Bolton NHS Foundation Trust screening service held on 8 December 2016 and the 3 February 2017. The QA visit team identified 10 high priority findings as

Screening Quality Assurance visit report NHS Cervical Screening Programme: University Hospitals of South Manchester NHS Foundation Trust – Public Health England

The findings in this report relate to the quality assurance (QA) visit of the University Hospitals of South Manchester NHS Foundation Trust screening service held on 10 November 2016. The QA visit team identified one immediate concern. A letter was sent to

Screening Quality Assurance visit report: NHS Cervical Screening Programme Colchester Hospital University NHS Foundation Trust – Public Health England

The findings in this report relate to the quality assurance visit of the Colchester Hospital University NHS Foundation Trust (CHUFT) screening service held on 2 November 2017. The QA visit team identified 13 high priority findings as summarised below: there is

Rebuilding my body: Breast reconstruction in England – Breast Cancer Now

Research from Breast Cancer Now into the availability of breast reconstruction surgery, that finds some Clinical Commissioning Groups (CCGs) in England are restricting access to this surgery. Since 2012, 22.6% of CCGs have introduced official policies restricting breast reconstruction surgery while a further 4.3% have policies that are either informal

Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma: Technology appraisal guidance [TA524] – NICE

Evidence-based recommendations on brentuximab vedotin (Adcetris) for treating CD30-positive Hodgkin lymphoma in adults. This guidance is a Cancer Drugs Fund reconsideration of brentuximab vedotin for treating CD30-positive Hodgkin lymphoma (TA446). This guidance replaces TA446.  

Screening Quality Assurance visit report: NHS Cervical Screening Programme East Lancashire Hospitals NHS Trust – Public Health England

Finds the service is well organised with the lead colposcopist providing strong leadership. Team members are engaged and motivated. A systematic and focused approach to quality improvement was evident with engagement in activities to reduce health inequalities and improve community engagement to

Screening Quality Assurance visit report: NHS Cervical Screening Programme Frimley Health NHS Foundation Trust – Public Health England

Executive summary of quality assurance (QA) visit to Frimley Health NHS Foundation Trust held on 9, 19 and 20 June 2017. The QA visit team identified 2 immediate concerns which were addressed within seven days of the visit. all colposcopy examinations must

The Hidden Cancer: The Need to Improve Blood Cancer Care – All-Parliamentary Group on Blood Cancer

All-Parliamentary Group on Blood Cancer report that makes important recommendations on how to make improvements and ensure that we all work together to raise awareness of blood cancer. It is also a call to the Government and NHS to ensure

Screening Quality Assurance visit report NHS Bowel Cancer Screening Programme: North East London Bowel Cancer Screening Centre

Executive summary of quality assurance (QA) visit to North East London Bowel Cancer Screening Centre held on 17 March 2017.  The QA visit team identified 9 high priority findings as summarised below: Barts Health NHS Trust does not have an agreed